Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease

Published: 2020-04-03

Affiliations: 7

Authors: 17

Institutions	Authors	Share
Eli Lilly and Company, United States of America (USA)		0.35
Department of Clinical Sciences - Malmö (DCSM), LU, Sweden		0.23
Janssen Research & Development, LLC, United States of America (USA)		0.18
Janssen Pharmaceutica, Belgium		0.12
Skåne University Hospital in Lund, SUS, Sweden		0.08
Minnessjukdomar, SUS, Sweden		0.03
Wallenberg Centre for Molecular Medicine (WCMM), LU, Sweden		0.02

Return

Latest supplement

Nature Index 2020 Artificial Intelligence

Artificial intelligence is one of the most rapidly advancing and controversial topics in scientific research. As investments and revenues soar year-on-year and nations vie for leadership in the field, AI research output continues its steep, upward trajectory. But there are significant ethical and technical challenges to overcome.

Access free

Research highlights of partners

Anatomy of the extinct

University College Cork (UCC)

30 Jan 2020

An unsung hero of carbon sequestration in the oceans

Spanish National Research Council (CSIC)

27 Feb 2020

First African analysis of schizophrenia genetics

University of Cape Town (UCT)

29 May 2020

Research highlights

Sign up for the free weekly Nature Index newsletter
Sign up